IP Library Granted Patent US 11,306,056
Granted Patent B2
US 11,306,056 · App. 17/093,506 · Granted Apr 19, 2022

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

Inventors: John P. Toscano (Glen Arm, MD); Frederick Arthur Brookfield (Abingdon, GB); Andrew D. Cohen (Mamaroneck, NY); Stephen Martin Courtney (Abingdon, GB); Lisa Marie Frost (Abingdon, GB); Vincent Jacob Kalish (Annapolis, MD)
Assignees: Cardioxyl Pharmaceuticals, Inc.; The Johns Hopkins University
C07C311/48C07C317/14C07C323/67C07D213/74C07D231/18C07D261/10C07D263/58C07D285/125C07D295/096C07D307/82C07D309/12C07D317/14C07D333/34C07D333/62Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,306,056
App. No.
17/093,506
Granted
Apr 19, 2022
Kind
B2
Abstract

The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.

Claims (48)

1. A method of preparing a compound of formula C2:

the method comprising (a) combining a compound of formula C1 with a compound of formula A1,

wherein:

the compound of formula C1 is:

and

the compound of formula A1 is:

and

wherein R is

and

R 3 , R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of H, halo, alkylsulfonyl, N-hydroxylsulfonamidyl, perhaloalkyl, nitro, aryl, cyano, alkoxy, perhaloalkoxy, alkyl, substituted aryloxy, alkylsulfanyl, alkylsulfinyl, heterocycloalkyl, substituted heterocycloalkyl, dialkylamino, cycloalkoxy, cycloalkylsulfanyl, arylsulfanyl and arylsulfinyl,

provided that: (1) at least one of R 3 , R 4 , R 5 , R 6 , and R 7 is other than H.

2. The method of claim 1 , wherein R 3 , R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of H, Cl, F, I, Br, SO 2 CH 3 , SO 2 NHOH, CF 3 , NO 2 , phenyl, CN, OCH 3 , OCF 3 , t-Bu, O-iPr, 4-nitrophenyloxy, propane-2-thiyl, propane-2-sulfinyl, morpholino, N-methyl-piperazino, dimethylamino, piperidino, cyclohexyloxy, cyclopentylsulfanyl, phenylsulfanyl and phenylsulfinyl.

3. The method of claim 1 , wherein one of R 3 , R 4 , R 5 , R 6 , and R 7 is halo.

4. The method of claim 3 , wherein one of R 3 , R 4 , R 5 , R 6 , and R 7 is bromo.

5. The method of claim 1 , wherein step (a) comprises the substep of combining a base with the compound of formula C1.

6. The method of claim 5 , wherein the base is potassium carbonate.

7. The method of claim 1 , wherein the compound of formula C2 is:

8. A method of preparing a compound of formula A2:

the method comprising:

(a) deprotecting the compound of formula C2 to form the compound of formula A2;

wherein:

the compound of formula C2 is:

and

and wherein, in the compounds of formulae A2 and C2:

R is:

and

R 3 , R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of H, halo, alkylsulfonyl, N-hydroxylsulfonamidyl, perhaloalkyl, nitro, aryl, cyano, alkoxy, perhaloalkoxy, alkyl, substituted aryloxy, alkylsulfanyl, alkylsulfinyl, heterocycloalkyl, substituted heterocycloalkyl, dialkylamino, cycloalkoxy, cycloalkylsulfanyl, arylsulfanyl and arylsulfinyl,

provided that: (1) at least one of R 3 , R 4 , R 5 , R 6 , and R 7 is other than H.

9. The method of claim 8 , wherein R 3 , R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of H, Cl, F, I, Br, SO 2 CH 3 , SO 2 NHOH, CF 3 , NO 2 , phenyl, CN, OCH 3 , OCF 3 , t-Bu, O-iPr, 4-nitrophenyloxy, propane-2-thiyl, propane-2-sulfinyl, morpholino, N-methyl-piperazino, dimethylamino, piperidino, cyclohexyloxy, cyclopentylsulfanyl, phenylsulfanyl and phenylsulfinyl.

10. The method of claim 8 , wherein one of R 3 , R 4 , R 5 , R 6 , and R 7 is halo.

11. The method of claim 10 , wherein one of R 3 , R 4 , R 5 , R 6 , and R 7 is bromo.

12. A method of preparing a compound of the formula A2:

the method comprising:

(a) combining a compound of formula C1 with a compound of formula A1 to form a compound of formula C2; and

(b) deprotecting the compound of formula C2 to form the compound of formula A2;

wherein:

the compound of formula C1 is:

the compound of formula A1 is:

the compound of formula C2 is:

and

and wherein, in the compounds of formulae A1, A2 and C2:

R is:

and

R 3 , R 4 , R 5 , R 6 , and R 7 are independently selected from the group consisting of H, halo, alkylsulfonyl, N-hydroxylsulfonamidyl, perhaloalkyl, nitro, aryl, cyano, alkoxy, perhaloalkoxy, alkyl, substituted aryloxy, alkylsulfanyl, alkylsulfinyl, heterocycloalkyl, substituted heterocycloalkyl, dialkylamino, cycloalkoxy, cycloalkylsulfanyl, arylsulfanyl and arylsulfinyl,

provided that: (1) at least one of R 3 , R 4 , R 5 , R 6 , and R′ is other than H.

13. The method of claim 12 , wherein R 3 , R 4 , R 5 , R 6 , and Ware independently selected from the group consisting of H, Cl, F, I, Br, SO 2 CH 3 , SO 2 NHOH, CF 3 , NO 2 , phenyl, CN, OCH 3 , OCF 3 , t-Bu, O-iPr, 4-nitrophenyloxy, propane-2-thiyl, propane-2-sulfinyl, morpholino, N-methyl-piperazino, dimethylamino, piperidino, cyclohexyloxy, cyclopentylsulfanyl, phenylsulfanyl and phenylsulfinyl.

14. The method of claim 12 , wherein one of R 3 , R 4 , R 5 , R 6 , and R 7 is halo.

15. The method of claim 14 , wherein one of R 3 , R 4 , R 5 , R 6 , and R 7 is bromo.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2022
From: CARDIOXYL PHARMACEUTICALS INC.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 062041/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: KALISH, VINCENT JACOB
To: CARDIOXYL PHARMACEUTICALS
Reel/Frame 054349/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: TOSCANO, JOHN P.; COHEN, ANDREW D.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 054349/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: BROOKFIELD, FREDERICK ARTHUR; COURTNEY, STEPHEN MARTIN; FROST, LISA MARIE
To: EVOTEC LTD.
Reel/Frame 054349/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: EVOTEC LTD.
To: CARDIOXYL PHARMACEUTICALS
Reel/Frame 054349/0448 →
Continuity (11)
Continuation 16685534 · Nov 15, 2019
Continuation 16243251 · Jan 9, 2019
Continuation 15961441 · Apr 24, 2018
Continuation 15640342 · Jun 30, 2017
Continuation 15286145 · Oct 5, 2016
Continuation 14857308 · Sep 17, 2015
Continuation 14280133 · May 16, 2014
Continuation 13213480 · Aug 19, 2011
Continuation 11724792 · Mar 16, 2007
Provisional Application 60783556 · Mar 17, 2006
Related Publication 20210053915A1 · Feb 25, 2021
Cited By (1)
US 12,186,301